切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2017, Vol. 11 ›› Issue (05) : 460 -463. doi: 10.3877/cma.j.issn.1674-1358.2017.05.007

临床论著

徐州市2 696例女性患者宫颈人乳头瘤病毒感染状况及基因分型
王莉娜1, 丁芹1,(), 潘玉1, 宋正霞1, 秦亚楠1, 张言超1, 颜学兵1   
  1. 1. 221002 徐州市,徐州医科大学附属医院感染性疾病科
  • 收稿日期:2016-09-27 出版日期:2017-10-15
  • 通信作者: 丁芹
  • 基金资助:
    国家自然科学基金面上项目(No. 81371867); 江苏省高校自然科学基础研究面上项目(No. 08KJD320012)

Cervical human papillomavirus infection and genotype distribution of 2 696 gynecological patients in Xuzhou

Li'na Wang1, Qin Ding1,(), Yu Pan1, Zhengxia Song1, Ya'nan Qin1, Yanchao Zhang1, Xuebing Yan1   

  1. 1. Department of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
  • Received:2016-09-27 Published:2017-10-15
  • Corresponding author: Qin Ding
引用本文:

王莉娜, 丁芹, 潘玉, 宋正霞, 秦亚楠, 张言超, 颜学兵. 徐州市2 696例女性患者宫颈人乳头瘤病毒感染状况及基因分型[J]. 中华实验和临床感染病杂志(电子版), 2017, 11(05): 460-463.

Li'na Wang, Qin Ding, Yu Pan, Zhengxia Song, Ya'nan Qin, Yanchao Zhang, Xuebing Yan. Cervical human papillomavirus infection and genotype distribution of 2 696 gynecological patients in Xuzhou[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2017, 11(05): 460-463.

目的

探讨本地区妇科患者宫颈人乳头瘤病毒(HPV)感染状况和基因型分布情况,为宫颈癌防治提供可靠依据。

方法

采用PCR斑点杂交技术对不同年龄段的女性宫颈脱落细胞标本进行HPV基因分型检测,根据基因型分为高危组、中高危组、低危组,分析HPV在女性人群中的感染率、基因型和年龄分布特点。

结果

2 696例患者共有HPV阳性1 272例,阳性率为47.18%。阳性病例中单一感染者780例(61.32%),重叠感染者492例(38.68%)。共检测到阳性例次2 053例次,其中高危型1 307例次(63.66%),中高危型271例次(13.20%),低危型475例次(23.14%)。HPV感染的阳性率以20岁及以下组患者为最高(66.67%),> 60岁组患者最低(39.06%),差异具有统计学意义(χ2 = 28.619、P < 0.001)。21~30岁组患者感染例次构成比为29.17%,31~40岁组患者为32.31%,41~50岁组患者为25.86%,患者高于其他各组,差异具有统计学意义(χ2 = 885.1、P < 0.001)。高危型中16、52、58型为主要的感染型别,低危型中6、11型为主要的感染型别,差异具有统计学意义(χ2= 1678、P < 0.001)。

结论

本地区妇科患者HPV感染以单一感染和高危感染为主,感染率最高的亚型是高危16型;不同年龄分层的感染率略有不同。

Objective

To investigate the prevalence of cervical human papillomavirus (HPV) infection and genotype distribution in this region, and to provide reliable basis for cervical cancer prevention.

Methods

The genotypes of HPV among women of different ages cervical exfoliated cells specimens were detected by PCR and hybridization technique. According to the genotype, patients were divided into high-risk group, middle-risk group and low-risk group. The infection rate, genotype and age distribution of HPV in the female population were analyzed, respectively.

Results

The positive rate was 47.18% (1 272/2 696). Among the positive 1 272 cases, the percentage of single HPV infection and multiple HPVs infection were 61.32% (780/1 272) and 38.68% (492/1 272). Positive cases was detected 2 053 cases, high-risk genotypes were found 1 307 times (63.66%) which was higher than 475 times in low risk (23.14%) and 271 (13.20%) times in middle-risk group. The positive rate of HPV infection in patients who were 20 or younger than 20 years old was 66.67%, meanwhile, it was 39.06% in patients older than 60 years old, with significant differences (χ2 = 28.619, P < 0.001). As to constituent ratio of positive cases, patients of 21 to 30 years old was 29.17%, patients of 31 to 40 years old was 32.31% and patients of 41 to 50 years old was 25.86%, which were higher than other groups, with significant differences (χ2 = 885.1, P < 0.001). Among the high-risk genotypes, HPV 16, 52, 58 were found more common than other genotypes. Among the low-risk genotypes, HPV 6, 11 were found more common than other genotypes, with significant difference (χ2 = 1 678, P < 0.001).

Conclusions

Single infection and high-risk infection took the main part in the HPV infection in the region of department of gynaecology patients, subtype of the highest infection rates are high risk 16 genotypes. There existed a slight difference in infection rates of different age groups.

表1 HPV各基因型感染情况分布[例(%)]
基因型 阳性率 阳性例数合计 构成比(%)
≤ 20岁(63例) 21~30岁(701例) 31~40岁(912例) 41~50岁(768例) 51~60岁(188例) > 60岁(64例)
HPV阳性率 42(66.67) 371(52.92) 411(45.07) 329(42.84) 94(50.00) 25(39.06) 2 053 100.00
HPV高危型                
  16 10(15.87) 83(11.84) 115(12.61) 102(13.28) 28(14.89) 9(14.06) 347 16.90
  52 8(12.70) 55(7.85) 59(6.47) 38(4.95) 20(10.64) 2(3.13) 182 8.87
  58 12(19.05) 41(5.85) 52(5.70) 45(5.86) 21(11.17) 6(9.38) 177 8.62
  31 5(7.94) 21(3.00) 20(2.19) 27(3.52) 11(5.85) 4(6.25) 88 4.29
  33 4(6.35) 29(4.14) 26(2.85) 19(2.47) 6(3.19) 4(6.25) 88 4.29
  68 6(9.52) 28(3.99) 25(2.74) 18(2.34) 3(1.60) 1(1.56) 81 3.95
  66 3(4.76) 27(3.85) 27(2.96) 16(2.08) 3(1.60) 0(0.00) 76 3.70
  18 5(7.94) 15(2.14) 26(2.85) 13(1.69) 4(2.13) 3(4.69) 66 3.21
  39 5(7.94) 16(2.28) 17(1.86) 8(1.04) 4(2.13) 2(3.13) 52 2.53
  56 0(0.00) 12(1.71) 11(1.21) 13(1.69) 8(4.26) 2(3.13) 46 2.24
  59 4(6.35) 15(2.14) 9(0.99) 7(0.91) 1(0.53) 2(3.13) 38 1.85
  51 1(1.59) 9(1.28) 11(1.21) 8(1.04) 5(2.66) 1(1.56) 35 1.70
  35 0(0.00) 6(0.86) 4(0.44) 1(0.13) 4(2.13) 1(1.56) 16 0.78
  45 0(0.00) 4(0.57) 5(0.55) 5(0.65) 0(0.00) 1(1.56) 15 0.73
HPV中高危型                
  53 8(12.70) 37(5.28) 53(5.81) 44(5.73) 11(5.85) 2(3.13) 155 7.55
  CP8304 5(7.94) 33(4.71) 33(3.62) 30(3.91) 11(5.85) 4(6.25) 116 5.65
HPV低危型                
  6 19(30.16) 102(14.55) 57(6.25) 35(4.56) 14(7.45) 3(4.69) 230 11.20
  11 15(23.81) 89(12.70) 54(5.92) 28(3.65) 10(5.32) 6(9.38) 202 9.84
  42 0(0.00) 5(0.71) 7(0.77) 6(0.78) 0(0.00) 2(3.13) 20 0.97
  44 0(0.00) 3(0.43) 3(0.33) 7(0.91) 1(0.53) 0(0.00) 14 0.68
  43 0(0.00) 1(0.14) 1(0.11) 4(0.52) 3(1.60) 0(0.00) 9 0.44
[1]
Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application[J]. Nat Rev Cancer,2002,2(5):342-350.
[2]
吉耀华, 陆春雪, 周伟强, 等. 人乳头瘤病毒与宫颈疾病关系的研究[J]. 中国妇产科临床杂志,2010,9(6):463-464.
[3]
温旺荣, 李莉, 钟玉婷, 等.应用改良导流杂交法检测103例妇女HPV基因型[J]. 暨南大学学报(医学版),2009,2(6):595-601.
[4]
Wheeler CM, Hunt WC, Joste NE, et al. Humanpapillo mavirus genotype distributions:implacationns For vaccination and cancer csreening in the United State[J]. J Natl Cancer Inst,2009,101(7):475-487.
[5]
Chen W, Zhang X, Molijn A, et al. Human paplillomavirus type-distribution in cervical cancer in China;the importance of HPV 16 and 18[J]. Cancer Causes Control,2009,20(9):1705-1713.
[6]
Dai Y, Huang YS, Tang M, et al. Distribution and clinical significance of human paplillomavirus subtypes in Shenzhen city, People’s Republic of China[J]. Int J Gynecol Cancer,2008,1(2):295-299.
[7]
Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance[J]. Gynecol Oncol,2015,136(2):178-182.
[8]
张敏鸽. 高危HPV与宫颈癌发生的相关性[J]. 实用癌症杂志,2012,27(6):670-672.
[9]
王稳, 于善萍, 刘晓虹, 等. 尖锐湿疣患者宫颈HP V分型检测[J]. 中国麻风皮肤病杂志,2016,32(5):307-308.
[10]
Printz C. FDA approves Gardasil 9 for more types of HPV[J]. Cancer,2015,121(8):1156-1157.
[11]
Cuzick J. Gardasil 9 joins the fight against cervix cancer[J]. Expert Rev Vaccines,2015,14(8):1047-1049.
[12]
Lamos C, Mihaljevic C, Aulmann S, et al. Detection of human papillomavirus infection in patients with vaginal intraepithelial neoplasia[J]. PLoS One,2016,11(12):e0167386.
[13]
米热古丽·阿克木江, 阿依米拉·艾山江, 苏莱娅·胡塞音, 等. HPV16在宫颈癌前病变及宫颈癌中的检测及临床意义[J]. 中国妇幼健康研究,2015,26(5):1016-1018.
[14]
Kim KS, Park SA, Ko KN, et al. Current status of human papillomavirus vaccines[J]. Clin Exp Vaccine Res,2014,3(2):168-175.
[15]
Herrero R, González P, Markowitz LE, et al. Present status of human papillomavirus vaccine development and implementation[J]. Lancet Oncol,2015,16(5):e206-e216.
[16]
张新, 王纯雁, 石菊芳, 等. 沈阳市妇女人乳头瘤病毒感染型别分布的研究[J]. 中华流行病学杂志,2007,28(10):954-957.
[17]
李灿, 陈伟, 赵静, 等. 妇科门诊病人HPV分型检测及感染情况分析[J]. 西南军医,2015,17(3):253-255.
[18]
杜宏, 索兰草, 刘红贤, 等. 甘肃地区女性宫颈感染的现状研究[J]. 暨南大学学报,2015,36(1):41-45.
[19]
周晓花, 罗家有, 朱琳, 等. 长沙市9471名女性公务员人乳头瘤病毒感染状况及亚型分布[J]. 中华流行病学杂志,2013,34(11):1157-1158.
[20]
崔燕红, 宛传丹, 赵一琳, 等. 常熟地区女性HPV感染及亚型分布调查研究[J]. 安徽医药,2014,18(1):81-83.
[21]
杨广宇, 徐美华, 崔卫东, 等. 浙江省杭嘉湖地区妇女宫颈人乳头瘤病毒感染情况分析[J]. 中华临床感染病杂志,2013,6(4):209-212.
[22]
俞志红, 张敏, 李艳红, 等. 秦皇岛市门诊妇女人类乳头瘤病毒感染情况分析[J]. 河北中医,2014,36(1):154-155.
[23]
方玉才, 王秋英, 杨燕飞, 等. 1 448例妇科患者HPV感染型别分布及临床分析[J]. 中华实验和临床病毒学杂志,2013,27(6):449-451.
[24]
Smith JS, Melendy A, Rana RK, et al. Age-specific prevalence of infection with human papillomavirus in females: a global review[J]. J Adolesc Health,2008,43(Suppl 4):S5-S25.
[25]
陈琪珍, 唐龙英, 孙延慰. HPV DNA检测及其在宫颈癌筛查中的临床价值[J]. 中华现代妇产科学杂志,2005,2(7):600-603.
[1] 卫怡妙, 李亚芹, 赵卫红. 环状RNA与宫颈癌发病机制的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(05): 512-516.
[2] 骞佩, 包瑛, 黄惠梅, 韩艳, 索磊, 杨楠, 安小敏, 党佳文. 常染色体隐性遗传多囊肾病患儿PKHD1基因变异的临床表型及基因型[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(05): 540-547.
[3] 李维, 莫俊俏. 儿童呼吸道耐药流感嗜血杆菌基因型鉴定及耐药分析对抗菌药物治疗选择的意义[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 315-323.
[4] 孙笑非, 顾依群, 王爱春, 王荔, 孟凡凡, 王军, 卢利娟. 细胞块p16/Ki-67双染对子宫颈炎患者宫颈上皮内瘤变的诊断价值[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(06): 418-425.
[5] 郑璇, 张宝, 李世龙, 张晓茹. 150例不同基因型慢性乙型肝炎患者逆转录聚合酶区耐药变异位点特征及耐药影响因素[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(02): 82-89.
[6] 刘东晓, 丁永斌, 单留群, 程功名. 酪氨酸蛋白激酶-2 rs2230724基因多态性与结直肠癌风险相关性研究[J]. 中华普外科手术学杂志(电子版), 2022, 16(06): 667-671.
[7] 李沐宸, 温星桥. 前列腺癌与微生物的联系[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(02): 188-192.
[8] 王莹莹, 王卡娜, 陈思敬, 王娜, 郑莹. 腹腔镜宫颈广泛切除术治疗特殊类型宫颈黏液性癌[J]. 中华腔镜外科杂志(电子版), 2022, 15(06): 372-375.
[9] 周灿坤, 李庆东, 江卓飞, 肇丽杰, 郑玉华, 柳晓春, 谢庆煌, 黄晓斌. 阴式广泛联合经阴道内镜腹膜外淋巴结切除术[J]. 中华腔镜外科杂志(电子版), 2022, 15(06): 368-371.
[10] 刘云玥, 范文生, 顾成磊, 马鑫, 刘洪一, 孟元光. 达芬奇机器人MDT模式全盆腔廓清术治疗晚期宫颈癌一例[J]. 中华腔镜外科杂志(电子版), 2022, 15(04): 249-251.
[11] 李秘, 邱华娟, 纪燕琴, 周明辉. P16、Ki67表达及病毒载量对宫颈上皮内瘤变Ⅱ合并高危型人乳头瘤病毒感染患者病变转归的影响[J]. 中华临床医师杂志(电子版), 2023, 17(03): 272-278.
[12] 朱琳琳, 赵帆, 闫琳琳, 郑凤芝, 王静, 胡守奎. 北京京西地区女性高危型HPV感染状况及基因型分析[J]. 中华临床医师杂志(电子版), 2022, 16(09): 897-901.
[13] 秦毓, 杨苗, 畅锴, 王舒宁. 山西省女性人乳头瘤病毒感染现状分析[J]. 中华临床实验室管理电子杂志, 2023, 11(02): 105-108.
[14] 孔倩, 白冠男, 周瑜, 闫波. 组织蛋白酶B基因启动子多态性与急性心肌梗死发病的关系[J]. 中华诊断学电子杂志, 2022, 10(03): 171-176.
[15] 尹嫚, 杨林青, 王云飞. 女性生殖道同期发生的黏液上皮化生和肿瘤的诊断学特征并文献复习[J]. 中华诊断学电子杂志, 2022, 10(03): 193-196.
阅读次数
全文


摘要